NEW YORK (GenomeWeb) – Sequenom today reported preliminary 2015 revenue of $128 million, below analyst estimates of $130 million.

The company also said it accessioned 42,000 total commercial diagnostic test samples in the fourth quarter, up from 41,000 in the third quarter. Of the 42,000 tests, 37,300 were noninvasive prenatal test samples. In addition, Sequenom accessioned 3,000 of its MaterniT Genome test in Q4, the assay's first full quarter of sales.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.

Researchers report that while host genetics influence the oral microbiome, they don't appear to affect cavity-causing microbes, the Economist says.

Pandas' gut microbiomes change as what they eat changes with the seasons, writes Discover's Inkfish blog.

In PLOS this week: comparative genomic study of malaria-linked macaque parasite, search for apple root reference genes, and more.